Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes (the AIM study): double blind, randomised, placebo controlled, multicentre trial
- PMID: 31619437
- PMCID: PMC6812614
- DOI: 10.1136/bmj.l5654
Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes (the AIM study): double blind, randomised, placebo controlled, multicentre trial
Erratum in
-
Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes (the AIM study): double blind, randomised, placebo controlled, multicentre trial.BMJ. 2020 Feb 11;368:m546. doi: 10.1136/bmj.m546. BMJ. 2020. PMID: 32046994 No abstract available.
Abstract
Objective: To assess the efficacy of three months of antibiotic treatment compared with placebo in patients with chronic low back pain, previous disc herniation, and vertebral endplate changes (Modic changes).
Design: Double blind, parallel group, placebo controlled, multicentre trial.
Setting: Hospital outpatient clinics at six hospitals in Norway.
Participants: 180 patients with chronic low back pain, previous disc herniation, and type 1 (n=118) or type 2 (n=62) Modic changes enrolled from June 2015 to September 2017.
Interventions: Patients were randomised to three months of oral treatment with either 750 mg amoxicillin or placebo three times daily. The allocation sequence was concealed by using a computer generated number on the prescription.
Main outcome measures: The primary outcome was the Roland-Morris Disability Questionnaire (RMDQ) score (range 0-24) at one year follow-up in the intention to treat population. The minimal clinically important between group difference in mean RMDQ score was predefined as 4.
Results: In the primary analysis of the total cohort at one year, the difference in the mean RMDQ score between the amoxicillin group and the placebo group was -1.6 (95% confidence interval -3.1 to 0.0, P=0.04). In the secondary analysis, the difference in the mean RMDQ score between the groups was -2.3 (-4.2 to-0.4, P=0.02) for patients with type 1 Modic changes and -0.1 (-2.7 to 2.6, P=0.95) for patients with type 2 Modic changes. Fifty patients (56%) in the amoxicillin group experienced at least one drug related adverse event compared with 31 (34%) in the placebo group.
Conclusions: In this study on patients with chronic low back pain and Modic changes at the level of a previous disc herniation, three months of treatment with amoxicillin did not provide a clinically important benefit compared with placebo. Secondary analyses and sensitivity analyses supported this finding. Therefore, our results do not support the use of antibiotic treatment for chronic low back pain and Modic changes.
Trial registration: ClinicalTrials.gov NCT02323412.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from governmental organisations Helse Sør-Øst and Helse Vest for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Antibiotic treatment In patients with chronic low back pain and Modic changes (the AIM study): study protocol for a randomised controlled trial.Trials. 2017 Dec 15;18(1):596. doi: 10.1186/s13063-017-2306-8. Trials. 2017. PMID: 29246188 Free PMC article. Clinical Trial.
-
Clinical effect modifiers of antibiotic treatment in patients with chronic low back pain and Modic changes - secondary analyses of a randomised, placebo-controlled trial (the AIM study).BMC Musculoskelet Disord. 2020 Jul 13;21(1):458. doi: 10.1186/s12891-020-03422-y. BMC Musculoskelet Disord. 2020. PMID: 32660517 Free PMC article. Clinical Trial.
-
Cost-utility analysis of antibiotic treatment in patients with chronic low back pain and Modic changes: results from a randomised, placebo-controlled trial in Norway (the AIM study).BMJ Open. 2020 Jun 15;10(6):e035461. doi: 10.1136/bmjopen-2019-035461. BMJ Open. 2020. PMID: 32546490 Free PMC article. Clinical Trial.
-
Total disc replacement for chronic back pain in the presence of disc degeneration.Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008326. doi: 10.1002/14651858.CD008326.pub2. Cochrane Database Syst Rev. 2012. PMID: 22972118 Review.
-
[Antibiotics should not be used for treating back pain due to Modic changes].Ugeskr Laeger. 2020 Oct 12;182(42):V06200476. Ugeskr Laeger. 2020. PMID: 33046199 Review. Danish.
Cited by
-
Preclinical development and characterisation of PP353, a formulation of linezolid for intradiscal administration.JOR Spine. 2024 Nov 14;7(4):e70010. doi: 10.1002/jsp2.70010. eCollection 2024 Dec. JOR Spine. 2024. PMID: 39544355 Free PMC article.
-
Pharmacokinetics of PP353, a formulation of linezolid for intervertebral disc administration, in patients with chronic low back pain and Modic change Type 1: A first-in-human, Phase 1b, open-label, single-dose study.JOR Spine. 2024 Nov 14;7(4):e70009. doi: 10.1002/jsp2.70009. eCollection 2024 Dec. JOR Spine. 2024. PMID: 39544354 Free PMC article.
-
Efficacy of stepped care treatment for chronic discogenic low back pain patients with Modic I and II changes.Interv Pain Med. 2023 Nov 15;2(4):100292. doi: 10.1016/j.inpm.2023.100292. eCollection 2023 Dec. Interv Pain Med. 2023. PMID: 39239218 Free PMC article.
-
From Modic to Disc Endplate Bone Marrow Complex - The Natural Course and Clinical Implication of Vertebral Endplate Changes.Global Spine J. 2024 Aug 1:21925682241271440. doi: 10.1177/21925682241271440. Online ahead of print. Global Spine J. 2024. PMID: 39090550 Free PMC article. Review.
-
The impact of the microbiota-gut-brain axis on endometriosis-associated symptoms: mechanisms and opportunities for personalised management strategies.Reprod Fertil. 2024 May 1;5(2):e230085. doi: 10.1530/RAF-23-0085. Online ahead of print. Reprod Fertil. 2024. PMID: 38739749 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
Associated data
LinkOut - more resources
Full Text Sources
Medical